Agios Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	44.79	36.5	26.82	14.24	-	-
Revenue Growth (YoY)	36.26%	36.07%	88.36%	-	-	-
Cost of Revenue	340.02	305.45	298.41	281.61	256.97	220.81
Gross Profit	-295.22	-268.95	-271.58	-267.37	-256.97	-220.81
Selling, General & Admin	180.37	156.78	119.9	121.67	121.45	115.11
Operating Expenses	180.37	156.78	119.9	121.67	121.45	115.11
Operating Income	-475.59	-425.74	-391.49	-389.05	-378.42	-335.92
Interest & Investment Income	61.98	48.08	33.34	12.79	0.84	6.61
Other Non Operating Income (Expenses)	3.47	6.49	6.06	16.6	21.07	-
EBT Excluding Unusual Items	-410.14	-371.17	-352.09	-359.65	-356.51	-329.31
Gain (Loss) on Sale of Assets	-	200	-	-	-	-
Other Unusual Items	-	889.14	-	127.85	-	-
Pretax Income	-410.14	717.97	-352.09	-231.8	-356.51	-329.31
Income Tax Expense	-8.88	44.24	-	-	-	-
Earnings From Continuing Operations	-401.27	673.73	-352.09	-231.8	-356.51	-329.31
Earnings From Discontinued Operations	-	-	-	-	1,961	1.94
Net Income	-401.27	673.73	-352.09	-231.8	1,605	-327.37
Net Income to Common	-401.27	673.73	-352.09	-231.8	1,605	-327.37
Shares Outstanding (Basic)	58	57	56	55	60	69
Shares Outstanding (Diluted)	58	58	56	55	60	69
Shares Change (YoY)	0.86%	4.02%	1.57%	-9.36%	-12.39%	15.01%
EPS (Basic)	-6.96	11.86	-6.33	-4.23	26.55	-4.74
EPS (Diluted)	-6.96	11.64	-6.33	-4.23	26.55	-4.74
Free Cash Flow	-414.09	-391.53	-297.06	-314.36	-413.06	-304.87
Free Cash Flow Per Share	-7.18	-6.76	-5.34	-5.74	-6.83	-4.42
Operating Margin	-1061.80%	-1166.47%	-1459.52%	-2732.07%	-	-
Profit Margin	-895.86%	1845.92%	-1312.63%	-1627.82%	-	-
Free Cash Flow Margin	-924.50%	-1072.73%	-1107.49%	-2207.58%	-	-
EBITDA	-470.31	-420.08	-384.86	-380.48	-369.18	-326.13
D&A For EBITDA	5.28	5.65	6.62	8.56	9.24	9.79
EBIT	-475.59	-425.74	-391.49	-389.05	-378.42	-335.92
Effective Tax Rate	-	6.16%	-	-	-	-
Revenue as Reported	44.79	36.5	26.82	14.24	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.